NeuBase Therapeutics (NBSE) Stock Chart & Stock Price History → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free NBSE Stock Alerts $0.38 -0.02 (-3.97%) (As of 01:39 PM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability NeuBase Therapeutics Stock Price Performance5 Day Performance-7.41%1 Month Performance-6.25%3 Month Performance-44.85%6 Month Performance-44.40%Year-To-Date Performance-49.33%1 Year Performance-90.13% Receive NBSE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NeuBase Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. NBSE Stock Chart for Friday, May, 10, 2024 NBSE Chart by TradingView NeuBase Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/09/2024$0.41$0.39-4.50%$0.41$0.3855,681 shs$1.46 million05/08/2024$0.40$0.41+2.22%$0.41$0.3754,522 shs$1.53 million05/07/2024$0.41$0.40-2.46%$0.43$0.3937,318 shs$1.50 million05/06/2024$0.41$0.41+1.26%$0.42$0.36157,656 shs$1.54 million05/03/2024$0.41$0.41-1.72%$0.42$0.40516,962 shs$1.52 million05/02/2024$0.42$0.41-0.94%$0.43$0.4126,712 shs$1.55 million Get the Latest News and Ratings for NBSE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NeuBase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/01/2024$0.42$0.42-1.42%$0.42$0.421,183 shs$1.56 million04/30/2024$0.42$0.42+0.88%$0.44$0.418,854 shs$1.58 million04/29/2024$0.44$0.42-4.85%$0.45$0.419,472 shs$1.57 million04/26/2024$0.44$0.44-0.54%$0.45$0.4172,166 shs$1.65 million04/25/2024$0.42$0.44+4.99%$0.45$0.4325,441 shs$1.66 million04/24/2024$0.42$0.42$0.45$0.4221,218 shs$1.58 million04/23/2024$0.41$0.42+2.43%$0.45$0.4058,425 shs$1.58 million04/22/2024$0.43$0.41-4.42%$0.42$0.40157,466 shs$1.54 million04/19/2024$0.42$0.41-2.69%$0.43$0.4188,865 shs$1.55 million04/18/2024$0.42$0.42+1.07%$0.44$0.4147,877 shs$1.59 million04/17/2024$0.40$0.42+3.70%$0.43$0.4030,890 shs$1.58 million04/16/2024$0.42$0.40-2.95%$0.42$0.4068,205 shs$1.52 million04/15/2024$0.44$0.42-4.90%$0.47$0.4134,974 shs$1.56 million04/12/2024$0.41$0.44+7.29%$0.44$0.4072,004 shs$1.54 million04/11/2024$0.40$0.41+2.53%$0.42$0.4013,064 shs$1.53 million04/10/2024$0.40$0.40+1.27%$0.41$0.3953,423 shs$1.49 million04/09/2024$0.41$0.40-3.06%$0.41$0.3949,361 shs$1.47 million04/08/2024$0.40$0.41+1.79%$0.42$0.3945,476 shs$1.52 million04/05/2024$0.43$0.40-7.19%$0.43$0.39118,287 shs$1.49 million04/04/2024$0.44$0.43-2.05%$0.45$0.4251,426 shs$1.61 million04/03/2024$0.43$0.44+3.29%$0.45$0.41215,420 shs$1.64 million04/02/2024$0.45$0.43-4.38%$0.45$0.4286,883 shs$1.59 million04/01/2024$0.45$0.45-0.98%$0.45$0.4378,758 shs$1.66 million03/29/2024$0.45$0.45$0.45$0.40284,674 shs$1.68 million03/28/2024$0.43$0.45+3.50%$0.45$0.40282,210 shs$1.68 million03/27/2024$0.48$0.43-9.21%$0.48$0.42644,832 shs$1.62 million03/26/2024$0.99$0.48-51.59%$0.54$0.431.37 million shs$1.79 million03/25/2024$1.03$0.99-3.97%$1.05$0.98666,856 shs$3.69 million03/22/2024$1.03$1.03$1.03$0.9833,202 shs$3.84 million03/21/2024$1.07$1.03-3.74%$1.10$0.95160,686 shs$3.84 million03/20/2024$1.03$1.07+3.88%$1.15$1.03182,202 shs$3.99 million03/19/2024$1.01$1.03+1.98%$1.05$0.99100,288 shs$3.84 million03/18/2024$0.97$1.01+4.23%$1.07$0.93264,901 shs$3.77 million03/15/2024$0.92$0.97+5.44%$0.98$0.8991,585 shs$3.61 millionBiggest hedge fund manager has huge warning for U.S. dollar (Ad)Prescient CEO Makes Shocking New Prediction Known for his eerily accurate market calls over the years, this CEO has just revealed his newest prediction about "America's New Money."Get the details before it's taken offline.03/14/2024$0.94$0.92-2.00%$0.94$0.9046,992 shs$3.43 million03/13/2024$0.95$0.94-1.28%$0.95$0.8758,609 shs$3.50 million03/12/2024$0.94$0.95+1.30%$0.96$0.8799,798 shs$3.54 million03/11/2024$0.93$0.94+0.76%$1.08$0.87259,303 shs$3.50 million03/08/2024$0.92$0.93+0.86%$0.96$0.88109,251 shs$3.46 million03/07/2024$0.90$0.92+2.21%$0.95$0.8720,833 shs$3.43 million03/06/2024$0.92$0.90-1.63%$0.94$0.87102,717 shs$3.36 million03/05/2024$0.87$0.92+4.99%$0.92$0.80186,994 shs$3.41 million03/04/2024$0.90$0.87-2.63%$0.89$0.8199,179 shs$3.25 million03/01/2024$0.86$0.90+4.07%$0.92$0.8667,951 shs$3.34 million02/29/2024$0.93$0.86-7.36%$0.98$0.8692,335 shs$3.21 million02/28/2024$0.91$0.93+1.93%$1.02$0.87391,804 shs$3.46 million02/27/2024$0.92$0.91-1.31%$0.96$0.85397,151 shs$3.40 million02/26/2024$0.71$0.92+29.57%$1.08$0.803.54 million shs$3.44 million02/23/2024$0.75$0.75-0.20%$0.77$0.712.95 million shs$2.80 million02/22/2024$0.72$0.75+4.34%$0.78$0.7256,191 shs$2.81 million02/21/2024$0.74$0.72-2.30%$0.80$0.7257,096 shs$2.69 million02/20/2024$0.69$0.74+6.80%$0.75$0.6694,689 shs$2.75 million02/19/2024$0.69$0.69$0.71$0.6810,400 shs$2.58 million02/16/2024$0.69$0.69+0.86%$0.71$0.6810,060 shs$2.58 million02/15/2024$0.69$0.69-0.71%$0.72$0.6843,761 shs$2.56 million02/14/2024$0.66$0.69+4.78%$0.70$0.6645,095 shs$2.57 million02/13/2024$0.68$0.66-3.02%$0.69$0.6612,321 shs$2.46 million02/12/2024$0.68$0.68-0.15%$0.70$0.688,433 shs$2.53 million02/09/2024$0.67$0.68+1.64%$0.68$0.6617,201 shs$2.50 million Related Companies: INM Stock Chart HSTO Stock Chart PBLA Stock Chart LSDI Stock Chart GLMD Stock Chart GRI Stock Chart ATNF Stock Chart PRFX Stock Chart QLGN Stock Chart BPTH Stock Chart Receive NBSE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NeuBase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NBSE) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis 1 Biotech Stock has been shocking the marketsHuge AlertsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuBase Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.